Financial Ratios

COROMANDAL BIOTECH INDUSTRIES INDIA LTD.

NSE : NABSE : 519293ISIN CODE : Industry : ChemicalsHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2014Mar2013Mar2012Mar2011Mar2010
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.220.23-0.29-0.31-0.28
   CEPS(Rs)0.060.52-0.01-0.020.01
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)2.512.732.502.793.04
   Tax Rate(%)21.25-32.0915.540.0014.28
Margin Ratios
   Core EBITDA Margin(%)0.00
   EBIT Margin(%)0.00
   Pre Tax Margin(%)0.00
   PAT Margin (%)0.00
   Cash Profit Margin (%)0.00
Performance Ratios
   ROA(%)-6.366.27-7.13-6.93-5.81
   ROE(%)-8.488.95-10.97-10.48-8.65
   ROCE(%)-10.776.78-12.98-10.47-10.08
   Asset Turnover(x)0.000.000.000.00
   Sales/Fixed Asset(x)0.000.000.000.00
   Working Capital/Sales(x)0.000.000.000.00
Efficiency Ratios
   Fixed Capital/Sales(x)0.00
   Receivable days0.00
   Inventory Days0.00
   Payable days
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)0.00
   EV/Core EBITDA(x)7789.9121.61-166.82-454.85-287.67
   EV/EBIT(x)-34.8756.18-29.00-32.66-31.13
   EV/CE(x)2.882.782.562.352.18
   M Cap / Sales0.00
Growth Ratio
   Net Sales Growth(%)
   Core EBITDA Growth(%)-99.73872.34-172.0036.80-61.20
   EBIT Growth(%)-259.21151.66-12.354.77-3.56
   PAT Growth(%)-195.03180.735.14-11.00-4.17
   EPS Growth(%)-195.03180.735.14-11.00-4.17
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)0.860.790.300.540.59
   Quick Ratio(x)0.860.790.300.540.59
   Interest Cover(x)-1925.881472.290.00-2453.11-755.92
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.